Shares of Shasun Pharmaceuticals ended 2% higher to Rs 172 after report says that the company has successfully completed US and Mexican drug regulator inspection at its active pharma ingredients (API) facility at Tamil Nadu.
The stock has hit a high of Rs196 and a low of Rs161.
No comments:
Post a Comment